OCON Healthcare develops innovative and safe medical solutions that are inspired by women’s bodies and anatomy, to better the lives of women everywhere.
In the past decade we have developed the IUB™ platform, our proprietary intrauterine ball-shaped technology, utilising super-elastic alloy Nitinol to carry long lasting hormone-free contraception and other drugs.
OCON’s first product, the IUB™ Ballerine®, is a CE approved copper-based hormone-free intrauterine contraceptive, effective for up to 5 years, and already in use by over 100,000 women in 24 countries, including EU member countries, South Africa and Israel.
The Company is currently enlisting patients for its phase II clinical trials with the IUB™ SEAD, a disposable, point of care therapy for the treatment of abnormal uterine bleeding (AUB), affecting 25% of women in the reproductive age. The SEAD (Spherical Endometrial Ablation Device) is designed to be a pain-free, non-invasive and cost-effective alternative for aggressive, invasive, painful and costly ablation procedures hundreds of thousands of women currently endure.
In addition, we are working on a strong pipeline of more IUB™ based drug products, using the frame for myomas and other uterine indications.
OCON’s technology platform and products are protected by a broad portfolio of patents and trademarks.
In the past decade we have developed the IUB™ platform, our proprietary intrauterine ball-shaped technology, utilising super-elastic alloy Nitinol to carry long lasting hormone-free contraception and other drugs.
OCON’s first product, the IUB™ Ballerine®, is a CE approved copper-based hormone-free intrauterine contraceptive, effective for up to 5 years, and already in use by over 100,000 women in 24 countries, including EU member countries, South Africa and Israel.
The Company is currently enlisting patients for its phase II clinical trials with the IUB™ SEAD, a disposable, point of care therapy for the treatment of abnormal uterine bleeding (AUB), affecting 25% of women in the reproductive age. The SEAD (Spherical Endometrial Ablation Device) is designed to be a pain-free, non-invasive and cost-effective alternative for aggressive, invasive, painful and costly ablation procedures hundreds of thousands of women currently endure.
In addition, we are working on a strong pipeline of more IUB™ based drug products, using the frame for myomas and other uterine indications.
OCON’s technology platform and products are protected by a broad portfolio of patents and trademarks.
Location: Israel, Center District, Modiin-Maccabim-Reut
Employees: 11-50
Total raised: $10M
Founded date: 2011
Investors 3
| Date | Name | Website |
| - | Astia Ange... | astia.org |
| 17.02.2022 | Cavendish ... | cavendishf... |
| - | Pontifax V... | pontifax.c... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 24.06.2024 | - | $10M | - |
Mentions in press and media 10
| Date | Title | Description |
| 15.08.2024 | Daniela Schardinger Honored as 40 Under 40 & Inspirational Woman 2024 for Pioneering Efforts in Elevating Women’s Health | Daniela Schardinger | Photo by Val Westover Recognized for transforming FemTech and championing women’s health, Daniela Schardinger leads the charge as a top innovator and advocate. Innovation, leadership, and equity are my driving forces. ... |
| 28.06.2024 | OCON Therapeutics: $10 Million Raised To Advance Women’s Health With Advanced Drug Delivery Solutions | OCON Therapeutics, a company at the forefront of transforming drug delivery, announced the successful completion of a $10 million investment round. This funding round was led by RH Capital, with participation from Features Capital, Astia An... |
| 24.06.2024 | Ocon Therapeutics Raises $10M in Funding | Ocon Therapeutics, a Modiin, Israel-based health company which specialised in drug delivery systems, raised $10M in funding. The round was led by RH Capital, with participation from Features Capital, Astia Angels, and Exerte Partners. The c... |
| 04.03.2021 | Femtech startup OCON Healthcare announces last patient in phase IIa clinical study, evaluating its intrauterine drug delivery platform IUB™ SEAD™, a non-invasive treatment for abnormal uterine bleedin... | MODIIN, Israel, March 4, 2021 /PRNewswire/ -- OCON Healthcare, a women's health company which develops, manufactures and commercializes an innovative 3D intrauterine drug delivery technology based on its patented IUB TM (Intra Uterine Ball)... |
| 04.03.2021 | Femtech startup OCON Healthcare announces last patient in phase IIa clinical study, evaluating its intrauterine drug delivery platform IUB™ SEAD™, a non-invasive treatment for abnormal uterine bleedin... | |
| 04.03.2021 | Dr. Robert Auerbach joins femtech startup OCON Healthcare’s Board of Directors – retired President of CooperSurgical | MODIIN, Israel, Feb. 4, 2021 /PRNewswire/ — OCON Healthcare, a femtech company which innovates, develops, manufactures, and commercializes ground breaking women’s health products based on its patented IUB™ (Intra Uterine Ball) smart 3D prop... |
| 04.02.2021 | Dr. Robert Auerbach joins femtech startup OCON Healthcare's Board of Directors - retired President of CooperSurgical | MODIIN, Israel, Feb. 4, 2021 /PRNewswire/ -- OCON Healthcare, a femtech company which innovates, develops, manufactures, and commercializes ground breaking women's health products based on its patented IUB™ (Intra Uterine Ball) smart 3D pro... |
| 21.01.2021 | These 3 Women Are Shaping The Future Of Women’s Health By Bringing Next Generation Of FemTech Products To The Market | breathe ilo, OCON Healthcare and Eli are three femtech startups innovating in the fertility and ... [+] contraception spaceVARIOUS |
| 21.12.2020 | FemTech startup OCON Healthcare completes funding round and appoints Dr. Anula Jayasuriya to Chairwoman | MODIIN, Israel, Dec. 21, 2020 /PRNewswire/ -- OCON Healthcare, a women's health company which develops, manufactures and commercializes innovative 3D intrauterine devices based on its patented IUB™ (Intra-Uterine Ball) platform, announced t... |
| - | Ocon Healthcare | “OCON Therapeutics Our mission is to introduce an innovative, high-quality intrauterine drug-delivery technology to improve and impact women’s health and quality of life Our Products OCON Healthcare Our mission is to introduce an innovativ... |